Vivien Jiaqian Zhu | Humanities | Best Researcher Award

Dr. Vivien Jiaqian Zhu | Humanities | Best Researcher Award

PhD at Stanford University and University of California, Berkeley, United States.

Vivien Jiaqian Zhu is a Ph.D. candidate at UC Berkeley and a visiting scholar at Stanford University, specializing in Japanese literature and art history. She has a diverse academic background, with studies spanning multiple prestigious institutions such as Harvard, Stanford, and Cambridge. Zhu’s research primarily focuses on East Asian languages and cultures, particularly on topics related to Japanese literature, art history, and the intersection of textuality and haptic aesthetics. She has demonstrated excellence through various honors, fellowships, and academic experiences, including her dissertation on the haptic beauty in Kawabata Yasunari’s works. Zhu has also presented at numerous international conferences and contributed significantly to the field through archival research, publications, and curatorial work.

Publication Profile

Orcid

Education 🎓

Vivien Jiaqian Zhu has pursued a diverse academic path across prestigious institutions. She is currently a Ph.D. candidate in Japanese Language and Literature at UC Berkeley, where she also received the Regent’s Fellowship. Her Master’s thesis focuses on Kawabata Yasunari’s works, exploring the tactile beauty in his Palm-of-the-Hand Stories. Zhu’s undergraduate studies at UC Berkeley culminated in an honors degree in Comparative Literature and Chinese Language, with a minor in the History of Art. She earned Phi Beta Kappa and other honors during her time at Berkeley. Zhu also studied advanced Japanese at the Inter-University Center for Japanese Language Studies in Yokohama and undertook language programs at Sophia University, Japan. Her academic pursuits also took her to Middlebury College and the Culinary Institute of America. At present, she is also studying Early Modern Japanese Palaeography at the University of Cambridge under the Mitsubishi Research Fellowship.

Experience 🩺

Vivien Jiaqian Zhu has accumulated extensive experience through her academic and professional roles. She is a visiting scholar at Stanford University, where she collaborates on research projects and participates in academic seminars. Zhu has also worked as a graduate student researcher at UC Berkeley, where she assisted in archival research and curated collections, focusing on Japanese literature and East Asian cultures. Her professional experience extends to editorial roles, including serving on the editorial board of the International Journal of Sustainable Fashion & Textile and as the editor of the Language & Theory section of Ling Mag. Zhu’s expertise is also reflected in her involvement in the International Joint Digital Center for Japanese Art and Culture at Ritsumeikan University. She has conducted research across various international libraries, including UC Berkeley, Nanjing University, and the University of Tokyo. Additionally, Zhu has gained teaching experience, particularly in Chinese calligraphy and East Asian studies.

Awards and Honors 🏅

Vivien Jiaqian Zhu’s academic excellence has been recognized through numerous prestigious awards and fellowships. In 2024, she received the Mitsubishi Research Fellowship for Early Modern Japanese Palaeography at the University of Cambridge, allowing her to study under the Emmanuel College at the university. Zhu has been honored with the Regent’s Fellowship for Graduate Study at UC Berkeley, nominated by Professor H. Mack Horton. She was awarded the CJS Graduate Student Fellowship, the UC Berkeley Departmental Award, and the Theresa Hak Kyung Cha Fellowship Award. Zhu’s academic recognition extends to memberships in Phi Beta Kappa and Golden Key International Honor Society. She has also earned multiple scholarships and fellowships, including the Nippon Foundation Fellowship for Japanese language studies at Stanford, the Dietrich von Bothmer Classical Scholarship, and the Institute of International Studies Undergraduate Merit Scholarship. Her research contributions have been consistently acknowledged, making her a prominent figure in East Asian literary studies.

Research Focus 🔬

Vivien Jiaqian Zhu’s research focuses on the intersection of Japanese literature, art history, and East Asian cultural studies. Her doctoral research at UC Berkeley explores the tactile and haptic elements in Kawabata Yasunari’s Palm-of-the-Hand Stories, examining how sensory experiences influence narrative structure and reader engagement. Zhu’s academic interests include the cultural and historical contexts of Japanese literature, with a particular emphasis on modern and early modern periods. She investigates the transnational connections between Japan, China, and the broader East Asian region, often incorporating interdisciplinary methodologies from comparative literature, art history, and cultural studies. Additionally, Zhu has worked on archival research projects, including studies of Chinese calligraphy, criminal law, and comparative law. Her studies in early modern Japanese palaeography and her deep engagement with East Asian art and literature reflect her broad intellectual interests, positioning her as a key scholar in understanding the intricate relationships between language, culture, and history in the region.

Conclusion

Vivien Jiaqian Zhu is an exceptionally talented researcher whose interdisciplinary approach and scholarly achievements make her an outstanding candidate for the Best Researcher Award. Her unique focus on the tactile aesthetics in Japanese literature and art, along with her academic excellence, make her stand out as a leader in her field. With a proven track record of global recognition and a commitment to advancing knowledge, Zhu’s continued contributions will undoubtedly have a lasting impact on the study of East Asian literature and art history.

Publication Top Notes 📚

  • “I Dwell in Possibility”: The Poetics of Space in the Works of 1980s Japanese Avant-Garde Fashion DesignersComparative Literature: East & West

    2024-12-08 | journal-article

    Source:Crossref

    DOI: 10.1080/25723618.2024.2433301

 

Hawraa Shbeeb | Medicine | Best Researcher Award

Dr. Hawraa Shbeeb | Medicine | Best Researcher Award

Fellowship in Infertility and IVF at Tehran University of Medical Sciences, Iran, Iran.

Dr. Hawraa Shbeeb is a dedicated Obstetrics and Gynecology Specialist currently pursuing a Fellowship in Infertility and IVF at Tehran University of Medical Sciences. She has significant international experience, registered as a specialist in both Iran and Lebanon, and is affiliated with several esteemed organizations like the Lebanese Society of Obstetrics and Gynecology (LSOG) and ISUGO. Her certifications demonstrate a commitment to continuous medical education, and she has contributed to research in infertility and reproductive health, with a recent publication in a peer-reviewed journal.

Publication Profile

Orcid

Education 🎓

Dr. Hawraa Shbeeb earned her Doctor of Medicine (MD) degree from Mashhad University of Medical Sciences (2009-2017). She specialized in Obstetrics and Gynecology at the same institution, completing her residency in December 2021. Currently, she is advancing her expertise through a Fellowship in Infertility and IVF at the prestigious Tehran University of Medical Sciences (2023-present). Her educational background also includes passing the Lebanese Colloquium Medicine Exam (2022), enabling her to practice in Lebanon. Her academic journey reflects a strong focus on women’s reproductive health, with an emphasis on infertility, assisted reproductive technologies, and high-risk pregnancies. Dr. Shbeeb’s pursuit of advanced certifications and continuous learning underscores her dedication to providing cutting-edge care in the field of reproductive medicine.

Experience 🩺

Dr. Hawraa Shbeeb has extensive experience as an Obstetrics and Gynecology Specialist. She has been practicing at the Imam Khomeini Hospital Complex in Tehran since January 2023. Previously, she served at the Imam Reza Hospital and Ghaem and Ommolbanin Hospitals in Mashhad, Iran (2017-2020). Dr. Shbeeb is also registered with the Lebanese Order of Physicians (LOP) and has been an active specialist in Lebanon since October 2022. Her affiliations with professional organizations like LSOG and ISUGO highlight her involvement in the global medical community. Additionally, she is a dedicated volunteer with the Iranian Red Crescent (2024-present), contributing to humanitarian efforts. Her experience spans clinical practice, research, and teaching, demonstrating a holistic approach to women’s healthcare.

Awards and Honors 🏅

Dr. Hawraa Shbeeb has earned multiple accolades for her contributions to healthcare and continuous education. She received the International Volunteer Day Award from the Iranian Red Crescent for her humanitarian work in Khorasan Razavi. Her certifications from esteemed bodies like ACOG, SAFOG, FOGSI, and the American Association for Continuous Education reflect her commitment to excellence in gynecology and reproductive health. Notable certifications include those in Minimal Access Surgery, Infertility & ARTs, Pregnancy Complications, and Fetal Medicine. She also holds certifications in Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life Support (PALS), and Basic Life Support (BLS) from Medtigo Health Education. These honors underscore her dedication to patient care, continuous learning, and professional excellence.

Research Focus 🔬

Dr. Hawraa Shbeeb’s research focuses on the fields of infertility, assisted reproductive technology (ART), and high-risk pregnancies. Her work addresses rare and complex gynecological cases, particularly those involving ectopic pregnancies and complications arising from embryo transfer procedures. Through her recent fellowship, she delves into advanced infertility treatments, IVF protocols, and improving outcomes for couples facing reproductive challenges. Dr. Shbeeb is dedicated to exploring new frontiers in minimal-access gynecological surgery, fetal medicine, and pregnancy complications. Her goal is to bridge clinical practice and research to enhance patient care. Her published case report on cornual pregnancy highlights her commitment to identifying and addressing rare medical conditions, providing valuable insights to the medical community.

Conclusion

Dr. Hawraa Shbeeb is a strong candidate for the Best Researcher Award due to her extensive clinical expertise, dedication to infertility research, and international professional affiliations. Her recent publication and ongoing fellowship in IVF indicate active engagement with cutting-edge reproductive medicine. Strengthening her research output and focusing on collaborative projects can further solidify her standing as a distinguished researcher in her field.

Publication Top Notes 📚

  • Title: Cornual Pregnancy as a Rare Entity of Ectopic Pregnancy After Assisted Reproductive Therapy‐Embryo Transfer (ART‐ET): A Case ReportPublication: Clinical Case Reports
    Year: 2024
    ISSN: 2050-0904Authors: Hawraa Hassan Shbeeb

 

 

Xiaoning wang | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Xiaoning wang | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Xiaoning wang, Department of Hematology, The First Affiliated Hospital of Xi’an Jiaotong University, China

Dr. Xiaoning Wang serves as the Deputy Director at The First Affiliated Hospital of Xi’an Jiaotong University. With over 17 years of medical expertise, Dr. Wang is an Associate Chief Physician specializing in hematopoietic stem cell transplantation and immunotherapy. 🧬✨ He has led notable research projects, including advancements in acute T-cell leukemia treatment and NK cell reconstruction. Dr. Wang has published extensively in renowned journals like Blood and Nature Communications 🩸📚 and holds multiple patents. A leader in the field, he is a key figure in various medical associations, driving innovation and collaboration in hematology. 🌐🎓

 

Publication Profile

Orcid

Academic and Professional Background 🎓💼

Assoc. Prof. Dr. Xiaoning Wang has a rich medical career spanning over 17 years. He currently serves as an Associate Chief Physician (Jan 2017 – Present), where he oversees advanced hematology treatments and research. Previously, he worked as an Attending Physician (Mar 2012 – Dec 2016), gaining extensive expertise in patient care and clinical decision-making. His medical journey began as a Resident Doctor (July 2006 – Feb 2012), where he honed his foundational skills in diagnostics and treatment. Dr. Wang’s professional growth reflects his dedication to medical excellence and patient-focused innovation. 🏥🩺✨

 

Research Contributions

Assoc. Prof. Dr. Xiaoning Wang is a prominent researcher whose work spans hematology, oncology, and infectious diseases. Key studies include identifying the novel HLA-C*14:02:01:33 allele via advanced sequencing techniques, optimizing treatment regimens for severe pneumocystis pneumonia, and investigating high NK cell levels in grafts reducing febrile neutropenia post-transplantation. Her pivotal work on molecular biomarkers in multiple myeloma and graft-versus-host disease therapies showcases her innovative approach to immunology and stem cell research. Dr. Wang has significantly contributed to international medical knowledge, with publications in Nature Communications, Blood, and JAMA Ophthalmology. 📚✨

Publication Top Notes 📚

  • The novel HLA-C*14:02:01:33 allele identified by Pacific Biosciences HiFi sequencing in a Chinese individual.
  • A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
  • Endogenous Aspergillus thermomutatus Endophthalmitis in a Patient With Myelodysplastic Syndrome.
  • High levels of NK Cells in graft are associated with reduced febrile neutropenia after haploidentical peripheral blood stem cell transplantation.
  • The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients.
  • Bloody tears as initial manifestation of rhino-orbital mucormycosis.
  • Pneumocystis jiroveci Pneumonia secondary to tyrosine kinase inhibitor with blinatumomab therapy: A case report.
  • ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
  • Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma.
  • Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report.
  • Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis.

 

Haojie Shan | Medicine | Best Researcher Award

Haojie Shan | Medicine | Best Researcher Award

Resident Surgeon at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School, China.

Dr. Haojie Shan is a dedicated resident surgeon specializing in orthopaedics at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. With a strong clinical and research foundation, Dr. Shan is passionate about advancing orthopaedic treatments, focusing on challenging areas such as osteonecrosis of the femoral head, bone immunity, and regeneration. His contributions to orthopaedics have been recognized through multiple prestigious awards, highlighting his commitment to innovation. Dr. Shan’s blend of clinical expertise and research excellence positions him as an emerging leader in orthopaedics, driven to enhance patient care and develop novel medical solutions.

Publication Profile

Scopus

Education

Dr. Shan completed his Ph.D. in Surgery (Orthopaedics) in 2023 at Shanghai Jiao Tong University, where he also earned his MD in 2020. He first obtained his Bachelor of Science in Clinical Medicine from Henan University in 2017. Each stage of his education has been marked by rigorous training, both in clinical practice and research, equipping him with a comprehensive understanding of orthopaedic medicine. This academic progression underscores Dr. Shan’s commitment to mastering complex medical challenges, particularly in his chosen field of orthopaedics, and provides a strong foundation for his clinical and research career.

Professional Experience

Currently, Dr. Shan is a resident surgeon in orthopaedics at Shanghai Sixth People’s Hospital. In this role, he has gained practical experience managing complex orthopaedic cases, with a focus on surgical techniques and postoperative care. His position at this leading hospital allows him to integrate his research insights with clinical practice, enhancing patient care with innovative approaches. His exposure to diverse cases has refined his skills in addressing issues like bone regeneration and infection control, which align with his research interests. Dr. Shan’s experience exemplifies his dedication to combining clinical expertise with research-driven improvements in orthopaedic care.

Research Focus

Dr. Shan’s research focuses on osteonecrosis of the femoral head, bone immunity, bone regeneration, and biomedical materials. His work seeks to address significant challenges in orthopaedic surgery, such as restoring bone function and preventing infection in complex cases. Dr. Shan is particularly interested in innovative treatments that promote healing and enhance patient outcomes. His research on bone and soft tissue infection and immunity explores the interactions between implants and the body’s immune response. Through his investigations, Dr. Shan aims to bridge scientific discovery and clinical application, advancing orthopaedic treatment methods and expanding therapeutic options in the field.

Awards and Honors

Dr. Shan has received multiple prestigious awards, reflecting his contributions to orthopaedics and medical innovation. In 2024, he won the Gold Award in the Shanghai Division and the National Silver Award at the International Innovation Competition for College Students in China. Additionally, he earned First Prize in the Rehabilitation Medicine and Engineering Innovation Competition (2023) and accolades for his papers at major conferences. His achievements also include third-place awards in the China Medical Device Innovation Competition and the Shanghai Orthopedics Annual Meeting. These recognitions underscore Dr. Shan’s dedication to advancing orthopaedic science and patient care.

Conclusion

Overall, Dr. Haojie Shan demonstrates strong qualifications for the “Best Researcher Award” based on his academic background, innovative research, and significant recognition within orthopaedics. Enhancing international visibility through collaborations and publications could further elevate his standing. Given his notable achievements and ongoing impact, he is a well-qualified candidate for the award.

Publication Top Notes 

Title: A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm
Authors: Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X.
Year: 2025
Journal: Carbohydrate Polymers, 347, 122723
Citations: 0

Title: Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections
Authors: Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X.
Year: 2024
Journal: Aggregate
Citations: 0

Title: An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing
Authors: Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C.
Year: 2024
Journal: Small Methods
Citations: 0

Title: Scd-1 deficiency promotes the differentiation of CD8+ T effector
Authors: Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X.
Year: 2024
Journal: Frontiers in Cellular and Infection Microbiology, 14, 1325390
Citations: 1

Title: Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways
Authors: Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X.
Year: 2023
Journal: Cell Proliferation, 56(11), e13485
Citations: 4

Title: Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α
Authors: Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T.
Year: 2023
Journal: Advanced Therapeutics, 6(3), 2200164
Citations: 2

Title: The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis
Authors: Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(4), pp. 240–245
Citations: 0

Title: Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination
Authors: Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(3), pp. 197–203
Citations: 0

Title: Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis
Authors: Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X.
Year: 2022
Journal: mSystems, 7(4)
Citations: 9

 

Fei Yu | Medicine and Dentistry | Best Researcher Award

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Ilaria Giangrandi | Medicine and Dentistry | Women Researcher Award

Dr. Ilaria Giangrandi | Medicine and Dentistry | Women Researcher Award

Dr. Ilaria Giangrandi, AOU CAREGGI FIRENZE, Italy

 

Based on the provided information, Dr. Ilaria Giangrandi seems to be a strong candidate for the Research for Women Researcher Award. Here’s a summary of her qualifications and contributions:

Publication profile

Professional Experience

2023: Assigned as a temporary substitute for the SODs of Clinical Nutrition at AOU Careggi. Participated in developing nutritional pathways for oncology patients in the Tuscany region and revising procedures for artificial nutrition in head and neck cancer cases.

2022: Responsible for scientific oversight of a training event on basal metabolism assessment via indirect calorimetry.

2021-2022: Member of the technical committee for ESTAR, focusing on the provision of special foods and supplements.

2020-Present: Quality and Safety Coordinator for Clinical Nutrition at AOU Careggi; Facilitator for Clinical Risk since November 2021.

Education and Training

2024: Attended multiple educational events, including courses on functional medicine, deontology, and care for migrant health.

2023: Participated in various courses related to metabolic syndrome, radioprotection, and microbiota.

2022: Engaged in training programs on specialized artificial nutrition and worker safety.

Communication Skills

  • Developed strong communication skills through courses in neurolinguistic programming and extensive clinical experience in various hospital departments.

Professional Skills

  • Demonstrated expertise in multidisciplinary team work and specialized clinical practices, including roles in vascular ecocolordoppler and upper abdomen diagnostics.

Publication Top Notes

  • Effects of a chronotype-adapted diet on weight loss, cardiometabolic health, and gut microbiota: study protocol for a randomized controlled trial
    Dinu, M., Lotti, S., Pagliai, G., … Colombini, B., Sofi, F.
    Trials, 2024, 25(1), 152
    🏷️ [No citations]
  • Licorice and liver function in patients with primary liver disease: A systematic review and meta-analysis of RCTs
    Giangrandi, I., Dinu, M., Napoletano, A., … Firenzuoli, F., Sofi, F.
    Phytotherapy Research, 2024
    🏷️ [No citations]
  • Assessment of Mediterranean diet adherence and comparison with Italian dietary guidelines: a study of over 10,000 adults from 2019 to 2022
    Lotti, S., Napoletano, A., Tristan Asensi, M., … Dinu, M., Sofi, F.
    International Journal of Food Sciences and Nutrition, 2024, 75(3), pp. 336–343
    🏷️ 2 citations
  • Quality of life and nutritional status of a group of post-operative head and neck cancer patients
    Asensi, M.T., Giangrandi, I., Sartini, L., … Colombini, B., Sofi, F.
    Nutricion Hospitalaria, 2023, 40(5), pp. 919–923
    🏷️ [No citations]
  • Adherence to the Mediterranean Diet and Ultra-Processed Foods Consumption in a Group of Italian Patients with Celiac Disease
    Tristan Asensi, M., Pagliai, G., Lotti, S., … Sofi, F., Dinu, M.
    Nutrients, 2023, 15(4), 938
    🏷️ 7 citations
  • Morning chronotype is associated with higher adherence to the Mediterranean diet in a sample of Italian adults
    Lotti, S., Pagliai, G., Asensi, M.T., … Sofi, F., Dinu, M.
    Nutrition, Metabolism and Cardiovascular Diseases, 2022, 32(9), pp. 2086–2092
    🏷️ 14 citations
  • Adherence to Mediterranean diet increased during the COVID-19 lockdown in Italy: results from the web-based Medi-Lite questionnaire
    Lotti, S., Dinu, M., Pagliai, G., … Colombini, B., Sofi, F.
    International Journal of Food Sciences and Nutrition, 2022, 73(5), pp. 650–656
    🏷️ 8 citations
  • Effects of vegetarian versus Mediterranean diet on kidney function: Findings from the CARDIVEG study
    Dinu, M., Colombini, B., Pagliai, G., … Marcucci, R., Sofi, F.
    European Journal of Clinical Investigation, 2021, 51(9), e13576
    🏷️ 7 citations
  • Adherence to Mediterranean diet measured through medi‐lite score and obesity: A retrospective study
    Dinu, M., Pagliai, G., Lotti, S., … Colombini, B., Sofi, F.
    Nutrients, 2021, 13(6), 2007
    🏷️ 8 citations
  • Effect of consumption of ancient grain bread leavened with sourdough or with baker’s yeast on cardio-metabolic risk parameters: a dietary intervention trial
    Pagliai, G., Venturi, M., Dinu, M., … Sofi, F., Granchi, L.
    International Journal of Food Sciences and Nutrition, 2021, 72(3), pp. 367–374
    🏷️ 10 citations

  
Conclusion

Dr. Giangrandi’s extensive involvement in clinical nutrition, educational contributions, and leadership in quality and safety make her a highly suitable candidate for the Research for Women Researcher Award.

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

 

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus